$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Extending the duration of drug release within the stomach during the fed mode 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/26
  • A61K-009/14
출원번호 US-0282233 (1999-03-29)
발명자 / 주소
  • John W. Shell
  • Jenny Louie-Helm
  • Micheline Markey
출원인 / 주소
  • DepoMed, Inc.
대리인 / 주소
    Townsend and Townsend and Crew LLP
인용정보 피인용 횟수 : 196  인용 특허 : 5

초록

Drugs are formulated as unit oral dosage forms by incorporating them into polymeric matrices comprised of hydrophilic polymers that swell upon imbibition of water to a size that is large enough to promote retention of the dosage form in the stomach during the fed mode. The oral formulation is design

대표청구항

1. A controlled-release oral drug dosage form for releasing a drug whose solubility in water is greater than one part by weight of said drug in ten parts by weight of water, said dosage form comprising a solid polymeric matrix with said drug dispersed therein at a weight ratio of drug to polymer of

이 특허에 인용된 특허 (5)

  1. Shell John W. (Hillsborough CA), Alkyl-substituted cellulose-based sustained-release oral drug dosage forms.
  2. Miller Ronald B. (Basel CHX) Leslie Stewart T. (Cambridge GB2) Malkowska Sandra T. A. (Cambridgeshire GB2) Smith Kevin J. (Cambridge GB2) Wimmer Walter (Limburg DEX) Winkler Horst (Linter DEX) Hahn U, Controlled release formulation.
  3. Royce Alan E. (Effort PA), Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms.
  4. Shell John W. ; Louie-Helm Jenny, Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter.
  5. Shell John W. (Hillsborough CA), Sustained-release oral drug dosage form.

이 특허를 인용한 특허 (196)

  1. Arkenau-Maric, Elisabeth; Bartholomaus, Johannes; Kugelmann, Heinrich, Abuse-proof dosage form.
  2. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  3. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  4. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  5. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  6. Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  7. Bartholomaus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  8. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  9. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  10. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  11. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  12. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  13. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai; Chow, San-Laung; Lin, Edward; Wong, David, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  14. Storm, Kevin H.; Conley, Creighton P.; Roush, John A., Amoxicillin and potassium clavulanate dosage form.
  15. Sesha, Ramesh, Anti-diabetic combinations.
  16. Rudnic,Edward M., Antibiotic composition with inhibitor.
  17. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  18. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  19. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  20. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  21. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  22. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  23. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  24. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antifungal once-a-day product, use and formulation thereof.
  25. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  26. Campos, Sebastien Andre; Harling, John David; Miah, Afjal Hussain; Smith, Ian Edward David, Benzothiophene derivatives as estrogen receptor inhibitors.
  27. Peter Timmins GB; Andrew B. Dennis GB; Kiren A. Vyas GB, Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
  28. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  29. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  30. Moshe Flashner-Barak IL; Vered Rosenberger IL; Mazal Dahan IL; Yitzhak Lerner IL, Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates.
  31. Storm, Kevin H.; Conley, Creighton P.; Roush, John A., Composition comprising amoxicillin and potassium clavulanate.
  32. Flashner-Barak, Moshe; Rosenberger, Vered; Lerner, E. Itzhak, Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation.
  33. Flanner, Henry H.; Guttendorf, Robert J.; Clausen, Susan P.; Treacy, Donald; Burnside, Beth A., Compositions and methods for improved efficacy of penicillin-type antibiotics.
  34. Storm,Kevin H.; Conley,Creighton P.; Roush,John A., Compositions and methods of treatment comprising amoxicillin and potassium clavulanate with xanthan.
  35. Campos, Sebastien Andre; Harling, John David, Compounds.
  36. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Aguilar, Alejandro A.; Wright, Claude E., Controlled release dosage form.
  37. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Aguilar, Alejandro A.; Wright, Claude E., Controlled release dosage form.
  38. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Aguilar, Alejandro A.; Wright, Claude E., Controlled release dosage form.
  39. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Aguilar, Alejandro A.; Wright, Claude E., Controlled release dosage form.
  40. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Aguilar, Alejandro A.; Wright, Claude E., Controlled release dosage form.
  41. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Aguilar, Alejandro A.; Wright, Claude E., Controlled release dosage form.
  42. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Aguilar, Alejandro A.; Wright, Claude E., Controlled release dosage form.
  43. Meyer, Glenn A.; Franco, Cristian R.; Fischbein, Gustavo A.; Wright, Claude E., Controlled release dosage form with enhanced pharmacokinetics.
  44. Frisbee, Steven, Controlled release dosage forms.
  45. Frisbee, Steven, Controlled release dosage forms.
  46. Cheng, Xiu Xiu; Jan, Steve; Chou, Joseph; Chen, Chih-Ming, Controlled release metformin formulations.
  47. Cheng, Xiu Xiu; Qi, Xiaohong; Zhang, Guohua; Dixit, Manesh, Diltiazem controlled release formulation and method of manufacture.
  48. Kumar, Vijai; McGuffy, Kevin Scott, Directly compressible extended-release matrix formulation for metformin hydrochloride.
  49. Arkenau-Marić, Elisabeth; Bartholomaeus, Johannes; Ziegler, Iris; Haupts, Marcel, Dosage form with impeded abuse.
  50. Friedl, Thomas; Brickl, Rolf-Stefan, Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof.
  51. Fix, Joseph A.; Shah, Shirish A.; Pilgaonkar, Pratibha S.; Gandhi, Anilkumar S., Extended release pharmaceutical formulations.
  52. Fix, Joseph A.; Shah, Shirish A.; Pilgaonkar, Pratibha S.; Gandhi, Anilkumar S., Extended release pharmaceutical formulations with controlled impurity levels.
  53. Fix, Joseph A.; Shah, Shirish A.; Pilgaonkar, Pratibha S.; Gandhi, Anilkumar S., Extended release pharmaceutical formulations with controlled impurity levels.
  54. Friedl, Thomas; Eisenreich, Wolfram, Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof.
  55. Friedl, Thomas; Eisenreich, Wolfram, Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof.
  56. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Extended-release minocycline dosage forms.
  57. Betterman, Sarah Michelle; Tantry, Jaidev Srinivas; Patrick, Laura Marie, Extended-release topiramate capsules.
  58. Betterman, Sarah Michelle; Tantry, Jaidev Srinivas; Patrick, Laura Marie, Extended-release topiramate capsules.
  59. Betterman, Sarah Michelle; Tantry, Jaidev Srinivas; Patrick, Laura Marie, Extended-release topiramate capsules.
  60. Betterman, Sarah Michelle; Tantry, Jaidev Srinivas; Patrick, Laura Marie, Extended-release topiramate capsules.
  61. Betterman, Sarah Michelle; Tantry, Jaidev Srinvas; Patrick, Laura Marie, Extended-release topiramate capsules.
  62. Shell, John W.; Louie-Helm, Jenny; Markey, Micheline, Extending the duration of drug release within the stomach during the fed mode.
  63. Berner, Bret; Hou, Sui Yuen Eddie, Gastric retained gabapentin dosage form.
  64. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M, Gastric retained gabapentin dosage form.
  65. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  66. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  67. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  68. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  69. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  70. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  71. Dudhara, Kamlesh Mohanlal; Dharmadhikari, Nitin Bhalachandra; Dhavse, Vaishali Vijay, Gastric retention controlled drug delivery system.
  72. Dudhara, Kamlesh Mohanlal; Dharmadhikari, Nitin Bhalachandra; Dhavse, Vaishali Vijay, Gastric retention controlled drug delivery system.
  73. Berner, Bret; Chen, Cuiping, Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract.
  74. Berner, Bret; Chen, Cuiping, Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract.
  75. Berner, Bret; Chen, Cuiping, Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract.
  76. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  77. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  78. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  79. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  80. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  81. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  82. Berner, Bret; Hou, Sui Yuen Eddie; Gana, Theophilus J.; Cramer, Marilou S., Gastric retentive gabapentin dosage forms and methods for using same.
  83. Berner, Bret; Louie-Helm, Jenny; Shell, John W., Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract.
  84. Berner, Bret; Louie-Helm, Jenny; Shell, John W., Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract.
  85. Bakan, Douglas A.; Jitpraphai, Waranush; Newhard, Steven B.; Wortzman, Mitchell S., Gastroretentive dosage forms for doxycycline.
  86. Bakan, Douglas A.; Jitpraphai, Waranush; Newhard, Steven B.; Wortzman, Mitchell S., Gastroretentive dosage forms for minocycline.
  87. Barnscheid, Lutz; Galia, Eric, Hot-melt extruded pharmaceutical dosage form.
  88. Sherman, Bernard Charles, Metformin hydrochloride tablets.
  89. DiMauro, Thomas M., Metformin-cysteine prodrug.
  90. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Method for the treatment of acne and certain dosage forms thereof.
  91. Piper, Beth Anne, Method for treating diabetes.
  92. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Stab, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Method of preparing sustained-release preparations of quinolone antibiotics.
  93. Storm,Kevin H.; Conley,Creighton P.; Roush,John A., Method of treating a bacterial infection.
  94. Conley, Creighton P.; Roush, John A.; Storm, Kevin H., Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate.
  95. Timmins, Peter; Dennis, Andrew B.; Vyas, Kiren A., Method of use of a biphasic controlled release delivery system for high solubility pharmaceuticals and method.
  96. Ghatnekar, Gautam S.; Brower, Justin, Methods and compositions for the treatment of metabolic disorders.
  97. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  98. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  99. Trotti, Davide; Pasinelli, Piera; Jablonski, Michael R., Methods of treating a neurodegenerative disease in a mammal in need thereof.
  100. Berner, Bret; Hou, Sui Yuen Eddie, Methods of treatment using a gastric retained gabapentin dosage.
  101. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  102. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  103. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  104. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  105. Berner,Bret; Hou,Sui Yuen Eddie; Gusler,Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  106. Berner, Bret; Hou, Sui Yuen Eddie, Methods of treatment using a gastric retained gabapentin dosage form.
  107. Devane,John; Cumming,K. Iain; Hou,Sui Yuen Eddie; Gusler,Gloria M., Methods of treatment using a gastric retained losartan dosage.
  108. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  109. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  110. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  111. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  112. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  113. Rahmouni, Miloud; Ferrada, Angela; Soulhi, Fouzia; Gervais, Sonia; Sant, Vinayak; Smith, Damon; Duffayet, Frederic; Rustom, Shams; El-Jammal, Ali; Ndong, Jean-Michel; Boursiquot, Bobby-Ernst; Bichara, Ali, Misuse preventative, controlled release formulation.
  114. Rahmouni, Miloud; Ferrada, Angela; Soulhi, Fouzia; Gervais, Sonia; Sant, Vinayak; Smith, Damon; Duffayet, Frederic; Rustom, Shams; El-Jammal, Ali; Ndong, Jean-Michel; Boursiquot, Bobby-Ernst; Bichara, Ali, Misuse preventative, controlled release formulation.
  115. Rahmouni, Miloud; Ferrada, Angela; Soulhi, Fouzia; Gervais, Sonia; Sant, Vinayak; Smith, Damon; Duffayet, Frederic; Rustom, Shams; El-Jammal, Ali; Ndong, Jean-Michel; Boursiquot, Bobby-Ernst; Bichara, Ali, Misuse preventative, controlled release formulation.
  116. Rahmouni, Miloud; Gervais, Sonia; Sant, Vinayak; Smith, Damon; Duffayet, Frederic; Rustom, Shams; El-Jammal, Ali; Ndong, Jean-Michel; Bichara, Ali, Misuse preventative, controlled release formulation.
  117. Rahmouni, Miloud; Gervais, Sonia; Sant, Vinayak; Smith, Damon; Duffayet, Frederic; Rustom, Shams; El-Jammal, Ali; Ndong, Jean-Michel; Bichara, Ali, Misuse preventative, controlled release formulation.
  118. Rahmouni, Miloud; Gervais, Sonia; Sant, Vinayak; Smith, Damon; Duffayet, Frederic; Rustom, Shams; El-Jammal, Ali; Ndong, Jean-Michel; Bichara, Ali, Misuse preventative, controlled release formulation.
  119. Flanner, Henry H.; Tolle-Sander, Sanna; Treacy, Donald; Burnside, Beth A.; Clausen, Susan P., Modified release amoxicillin products.
  120. Vaya, Navin; Karan, Rajesh Singh; Nadkarni, Sunil Sadanand; Gupta, Vinod Kumar, Modified release composition for highly soluble drugs.
  121. Vaya, Navin; Karan, Rajesh Singh; Nadkarni, Sunil Sadanand; Gupta, Vinod Kumar, Modified release composition of highly soluble drugs.
  122. Vaya, Navin; Karan, Rajesh Singh; Nadkarni, Sunil Sadanand; Gupta, Vinod Kumar, Modified release composition of highly soluble drugs.
  123. Seth, Pawan; Maes, Paul J., Modified release compositions of at least one form of tramadol.
  124. Seth, Pawan; Maes, Paul J., Modified release formulations of at least one form of tramadol.
  125. Conley, Creighton P.; Roush, John A.; Storm, Kevin H., Modified release pharmaceutical formulation comprising amoxycillin.
  126. Conley, Creighton P.; Roush, John A.; Storm, Kevin H., Modified release pharmaceutical formulation comprising amoxycillin.
  127. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  128. Barnscheid, Lutz; Wening, Klaus; Pätz, Jana; Geissler, Anja, Multiparticles safeguarded against ethanolic dose-dumping.
  129. Kim, Sung Wuk; Jun, Sung Soo; Jo, Young Gwan; Koo, Ja Seong; Kim, Young Woong, N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same.
  130. Kim, Sung Wuk; Jun, Sung Soo; Jo, Young Gwan; Koo, Ja Seong; Kim, Young Woong, N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same.
  131. Rudnic, Edward M; Isbister, James D; Treacy, Jr., Donald J; Wassink, Sandra E, Once a day amoxicillin product comprising immediate and delayed release dosage forms.
  132. Li, Boying; Nangia, Avinash; Browder, Monte, Oral extended-release composition.
  133. Li,Boyong; Nangia,Avinash; Browder,Monte, Oral extended-release composition.
  134. Barnscheid, Lutz; Galia, Eric; Schwier, Sebastian; Bertram, Ulrike; Geissler, Anja; Griessmann, Kornelia; Bartholomäus, Johannes, Oxidation-stabilized tamper-resistant dosage form.
  135. Kao, Haui-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  136. Kao, Huai-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  137. Flanner, Henry H.; Guttendorf, Robert; Treacy, Donald; Clausen, Susan P.; Burnside, Beth A., Pharmaceutical compositions and methods for improved bacterial eradication.
  138. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  139. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  140. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Ziegler, Iris; Schüssele, Andrea, Pharmaceutical dosage form.
  141. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Ziegler, Iris; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Schüessele, Andrea, Pharmaceutical dosage form.
  142. Haupts, Marcel, Preparation of a powdery pharmaceutical composition by means of an extruder.
  143. Faure, Anne; Voorspoels, Jody Firim Marceline; Mertens, Roel Jos M.; Kiekens, Filip René Irena, Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet.
  144. Arkenau, Elisabeth; Bartholomāus, Johannes, Process for the production of an abuse-proofed solid dosage form.
  145. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Process for the production of an abuse-proofed solid dosage form.
  146. Antarkar, Amit Krishna; Lala, Rajendra Ghanshamlal; Kamdar, Nirav Mahendra; Gadkari, Parag Narayan; Shah, Maya Janak; Shah, Janak Ramanlal, Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides.
  147. Fleshner-Barak, Moshe; Lerner, E. Itzhak; Rosenberger, Vered; Dahan, Mazal; Makov, Yisrael, Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition.
  148. Cao, Bruce X.; Burnside, Beth A.; Wassink, Sandra E.; Baker, Matt R., Robust pellet.
  149. Storm,Kevin H.; Conley,Creighton P.; Roush,John A., Second release phase formulation.
  150. Jain, Subheet; Dhaliwal, Sumeet; Rana, Madhu; Singh, Hardevinder Pal; Tiwary, Ashok Kumar, Sustained release drug delivery system.
  151. Sanghvi,Pradeep P.; Ketsela,Sara, Sustained release formulations of metformin.
  152. Baichwal,Anand R.; Kao,Huai Hung; McCall,Troy W., Sustained release formulations of oxymorphone.
  153. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Stab, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Sustained-release preparations of quinolone antibiotics.
  154. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Staβ, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Sustained-release preparations of quinolone antibiotics and method for preparation thereof.
  155. Amidon, Gregory Everett; Ganorkar, Loksidh Devi; Heimlich, John Mark; Lee, Ernest J.; Noack, Robert Martin; Reo, Joseph Peter; Skoug, Connie Jo, Sustained-release tablet composition of pramipexole.
  156. Cao, Bruce; Wassink, Sandra E.; Treacy, Jr., Donald J.; Burnside, Beth A.; Rowlings, Colin E.; Bonck, John A., Tablet for pulsed delivery.
  157. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
  158. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
  159. Barnscheid, Lutz; Schwier, Sebastian; Bartholomäus, Johannes, Tamper resistant dosage form comprising an anionic polymer.
  160. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Strauch, Stefanie; Pätz, Jana; Schwier, Sebastian, Tamper resistant dosage form with bimodal release profile.
  161. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  162. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  163. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  164. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  165. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  166. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  167. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  168. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  169. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  170. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  171. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  172. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  173. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  174. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  175. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  176. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  177. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  178. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  179. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  180. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  181. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  182. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  183. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  184. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  185. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  186. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  187. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  188. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  189. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  190. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  191. Friedrich, Ingo; Fuhrherr, Richard; Möschter, Silke; Wengner, Simone, Tamper resistant immediate release capsule formulation comprising tapentadol.
  192. Barnscheid, Lutz; Redmer, Jessica; Schwier, Sebastian, Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer.
  193. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Pätz, Jana, Tamper-resistant dosage form containing one or more particles.
  194. Wening, Klaus; Geiβler, Anja; Denker, Jana; Barnscheid, Lutz, Tamper-resistant dosage form with immediate release and resistance against solvent extraction.
  195. Schwier, Sebastian; Haupts, Marcel; Barnscheid, Lutz; Pätz, Jana, Tamper-resistant tablet providing immediate drug release.
  196. Barnscheid, Lutz; Galia, Eric; Geißler, Anja; Pätz, Jana; Schwier, Sebastian; Baronsky-Probst, Julia, Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로